TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Uniq Bioresearch Oy
Closing information (x1000 SEK)
Closing information | 2016/12 | 2015/12 | 2014/12 |
Turnover |
651
|
375
|
638 |
Financial expenses |
38
|
0
|
209 |
Earnings before taxes |
-191
|
-365
|
-485 |
Total assets |
4,276
|
5,216
|
3,625 |
Current assets |
153
|
2,211
|
29 |
Current liabilities |
2,086
|
3,216
|
1,180 |
Equity capital |
1,071
|
1,389
|
1,789 |
- share capital |
354
|
338
|
12,798 |
Employees (average) | 3 | 2 |
Financial ratios
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Solvency |
25.0%
|
26.6%
|
49.4% |
Turnover per employee | 217 | 319 | |
Profit as a percentage of turnover |
-29.3%
|
-97.3%
|
-76.0% |
Return on assets (ROA) |
-3.6%
|
-7.0%
|
-7.6% |
Current ratio |
7.3%
|
68.8%
|
2.5% |
Return on equity (ROE) |
-17.8%
|
-26.3%
|
-27.1% |
Change turnover |
258
|
-238 | |
Change turnover % |
66%
|
-39% | |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.